Allarity Therapeutics, Inc.
ALLRNasdaqCIK 1860657HealthcareFiscal year ends Dec 31
Reports and events: 206 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-3016:05 ET | 8-K | 1.02 Termination of a material agreement | 0001213900-26-114380 |
| 2026-10-0108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-105457 |
| 2026-09-2908:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-104317 |
| 2026-09-1608:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100350 |
| 2026-09-1412:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-099576 |
| 2026-08-1416:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090183 |
| 2026-08-1408:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027830 |
| 2026-07-0108:05 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-073998 |
| 2026-06-2208:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-070382 |
| 2026-06-0217:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-064278 |
| 2026-05-1516:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017371 |
| 2026-05-0817:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-054019 |
| 2026-05-0608:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-052542 |
| 2026-04-3016:12 ET | DEF 14A | Proxy statementPeriod 2026-06-26 | 0001213900-26-050231 |
| 2026-04-2808:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-048277 |
| 2026-04-2208:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-046411 |
| 2026-04-0108:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-038061 |
| 2026-03-3017:29 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010310 |
| 2026-03-0909:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-024952 |
| 2026-03-0608:22 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-024339 |
| 2026-02-1908:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-018161 |
| 2026-02-0408:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-011826 |
| 2026-01-2907:49 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-009157 |
| 2025-12-2309:21 ET | 8-K | 3.02 Unregistered sale of equity | 0001213900-25-124935 |
| 2025-12-0809:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-118989 |
| 2025-11-1409:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-035003 |
| 2025-09-2407:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-090872 |
| 2025-09-2217:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-090197 |
| 2025-09-2218:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-089680 |
| 2025-08-2708:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-080923 |
| 2025-08-1516:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-027146 |
| 2025-07-1607:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-064456 |
| 2025-07-0708:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-061639 |
| 2025-07-0116:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-060366 |
| 2025-06-3008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-021482 |
| 2025-06-1716:21 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-020652 |
| 2025-06-1116:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-020081 |
| 2025-06-0508:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019471 |
| 2025-06-0308:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019219 |
| 2025-05-1308:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-016264 |
| 2025-05-0916:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015780 |
| 2025-05-0916:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015778 |
| 2025-04-3017:27 ET | DEF 14A | Proxy statementPeriod 2025-06-13 | 0001437749-25-013914 |
| 2025-04-2808:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013236 |
| 2025-04-1616:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list | 0001437749-25-012153 |
| 2025-03-3116:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-010198 |
| 2025-03-3116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-010187 |
| 2025-03-2516:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-009132 |
| 2025-03-1808:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-008139 |
| 2025-03-1408:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-007620 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.